Drug Trial Radar · NCT00198510
Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
Last checked: Nov 20, 2026Latest source record: Mar 15, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
750
Actual
Start
Nov 1998
Primary completion
Sep 2001
Study completion Mar 2003
Sponsor
- Lead sponsor
- Bausch & Lomb IncorporatedIndustry
- Sponsor type
- Industry
- First posted
- Sep 20, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if intravitreal injection of Vitrase (ovine hyaluronidase) clears vitreous hemorrhage
Conditions
- Vitreous Hemorrhage
- Diabetic Retinopathy
Interventions
VitraseDrug
7.5 IU of Vitrase
VitraseDrug
55 IU of Vitrase
VitraseDrug
75 IU of Vitrase
Primary outcomes
What the sponsor says the trial is designed to measure.
- Resolution of Vitreous HemorrhageTime frame: 3 months
Locations
73 sites in 3 countries. Site status is shown where the registry gives one.
Retina Centers, PC
Tucson, Arizona
Retina Vitreous Associates Medical Group
Beverly Hills, California
Maria E. Castillejos, MD
Chula Vista, California
Natural Vision
Fresno, California
Eye Medical Center of Fresno
Fresno, California
Jerry Sebag, MD
Huntington Beach, California
University of California, Irvine
Irvine, California
California VitreRetinal Center
Menlo Park, California
Southern California Desert Retina Consultants
Palm Springs, California
Retinal Consultants
Sacramento, California
H. Richard McDonald, MD
San Francisco, California
Santa Clara Valley Medical Centre
San Jose, California
Robert L. Avery, MD
Santa Barbara, California
Olive View/UCLA Medical Center
Sylmar, California
Retina Consultants of Southern Colorado
Colorado Springs, Colorado
University of Colorado Health Sciences Center
Denver, Colorado
Danbury Eye Physicians & Surgeons
Danbury, Connecticut
New England Retina Associates
Hamden, Connecticut
Florida Eye Clinic
Altamonte Springs, Florida
Eye Centers of Florida
Fort Myers, Florida
Sarasota Retina Institute
Sarasota, Florida
Scott E. Pautler, MD
Tampa, Florida
Retina Center at Pali Momi
‘Aiea, Hawaii
Illinois Retina Associates SC
Chicago, Illinois
University of Chicago
Chicago, Illinois
American Eye Institute
New Albany, Indiana
Felix N. Sabates Eye Associates
Prairie Village, Kansas
King Y. Lee, MD
Shawnee Mission, Kansas
Kurt A. Gitter, MD
New Orleans, Louisiana
Retina Specialists
Baltimore, Maryland
Wilmer Eye Institute/Johns Hopkins University School of Medicine
Baltimore, Maryland
Retina Consultants, PC
Bethesda, Maryland
Schepens Retina Associates
Boston, Massachusetts
VitreoRetinal Associates
Grand Rapids, Michigan
Retina Center PA
Minneapolis, Minnesota
Hunkeler Eye Centers
Kansas City, Missouri
Retina Associates of Kansas City
Kansas City, Missouri
The Center for Advanced Medicine/Barnes Retina Institute
St Louis, Missouri
Robert Wood Johnson Medical School/Retina Vitreous Center
New Brunswick, New Jersey
Retina Associates of New Jersey
Teaneck, New Jersey
Showing 40 of 73 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.